ATE328595T1 - Carvedilolpolymorph - Google Patents

Carvedilolpolymorph

Info

Publication number
ATE328595T1
ATE328595T1 AT02761099T AT02761099T ATE328595T1 AT E328595 T1 ATE328595 T1 AT E328595T1 AT 02761099 T AT02761099 T AT 02761099T AT 02761099 T AT02761099 T AT 02761099T AT E328595 T1 ATE328595 T1 AT E328595T1
Authority
AT
Austria
Prior art keywords
carvedilol
polymorphous
relates
pharmaceutical compositions
novel crystalline
Prior art date
Application number
AT02761099T
Other languages
English (en)
Inventor
Wei Chen
Marc Gallop
Choon K Oh
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26974678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE328595(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE328595T1 publication Critical patent/ATE328595T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
AT02761099T 2001-07-13 2002-07-15 Carvedilolpolymorph ATE328595T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30559301P 2001-07-13 2001-07-13
US31415001P 2001-08-22 2001-08-22

Publications (1)

Publication Number Publication Date
ATE328595T1 true ATE328595T1 (de) 2006-06-15

Family

ID=26974678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761099T ATE328595T1 (de) 2001-07-13 2002-07-15 Carvedilolpolymorph

Country Status (6)

Country Link
EP (1) EP1406614B1 (de)
JP (1) JP2004534840A (de)
AT (1) ATE328595T1 (de)
AU (1) AU2002326391A1 (de)
DE (1) DE60212130D1 (de)
WO (1) WO2003005970A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699997B2 (en) 2000-06-28 2004-03-02 Teva Pharmaceutical Industries Ltd. Carvedilol
PL371409A1 (en) 2002-01-15 2005-06-13 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
WO2006135757A1 (en) * 2005-06-09 2006-12-21 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
GB2630462A (en) * 2023-05-11 2024-11-27 Catalent Uk Swindon Zydis Ltd Increasing permeation for pre-gastric absorption of active pharmaceutical ingredients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0893440A1 (de) * 1997-07-22 1999-01-27 Roche Diagnostics GmbH Eine thermodynamisch stabile Modifikation von 1-(4-Carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, Verfahren zu ihrer Herstellung und ihre enthaltende Arznemittel

Also Published As

Publication number Publication date
AU2002326391A1 (en) 2003-01-29
WO2003005970A2 (en) 2003-01-23
EP1406614A4 (de) 2005-02-09
EP1406614A2 (de) 2004-04-14
DE60212130D1 (en) 2006-07-20
WO2003005970A3 (en) 2003-05-01
EP1406614B1 (de) 2006-06-07
JP2004534840A (ja) 2004-11-18

Similar Documents

Publication Publication Date Title
CY1117051T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν κρυσταλλικη μορφη (i) της υδροχλωριουχου λερκανιδιπινης
AP1830A (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same.
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
CY1117639T1 (el) Φαρμακευτικες συνθεσεις βασιζομενες επι κρυσταλλικης μορφης i της 5-αζακυτιδινης
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
DK1379239T3 (da) N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
SE0101675D0 (sv) Novel composition
DE60225040D1 (de) Montelukast-granulatformulierung
NO20034660D0 (no) Spiropyrazolforbindelser
IL175512A0 (en) Methods of preparing aripiprazole crystalline forms
BR0211972A (pt) Composição oftálmica
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
SE9901077D0 (sv) Novel use
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
CY1108224T1 (el) Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα
SE9801494D0 (sv) Novel use
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
TW200745039A (en) Isotopically substituted pantoprazole
ATE328595T1 (de) Carvedilolpolymorph
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
NO20063293L (no) Farmasoytiske forbindelser
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
CY1105798T1 (el) Στepοειδη, η παρασκευη τους, φαρμακευτικες συνθεσεις απο αυτα και χρησεις των ενωσεων

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties